Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function

Overview of attention for article published in Cell Research, July 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 10 X users
patent: 4 patents

wikipedia: 1 Wikipedia page

Readers on

mendeley: 207 Mendeley

Summary X Patents Wikipedia

So far, Altmetric has seen 4 patents that reference this research output.

Anti-B7-H3 antibody and use thereof

Grant US-11891445-B1

United States of America

THERAPY FOR THE TREATMENT OF CANCER

Application EP-4081248-A4

European Patent Office

ANTI-B7-H3 ANTIBODY AND APPLICATION THEREOF

Application WO-2021052307-A1

World Intellectual Property Organisation (WIPO)

ANTI-B7-H3 ANTIBODY AND USE THEREOF

Application WO-2019226017-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.